Nephraegis Therapeutics
Hospitals & Physicians Clinics · Illinois, United States · <25 Employees
View Company Info for Free
About
Headquarters
100 Saunders Rd Ste 1501041, Lake Forest, Illin...Phone Number
(815) 687-6843Website
www.nephraegis.comRevenue
<$5 MillionIndustry
Recent News & Media
Who is Nephraegis Therapeutics
Nephraegis Therapeutics Org Chart
Is Nephraegis Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Nephraegis Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Nephraegis Therapeutics is spiking on competitors!
Product Launch: Get notified when Nephraegis Therapeutics launches new products
Funding: Get notified immidiatlly once Nephraegis Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Nephraegis Therapeutics
Click to see if Nephraegis Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Nephraegis Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Nephraegis Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Nephraegis Therapeutics
Find more new buyers
Compare Similar Companies to Nephraegis Therapeutics
Compare insights from companies similar to Nephraegis Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nephraegis Therapeutics
Nephraegis Therapeutics Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Nephraegis Therapeutics Tech Stack
A closer look at the technologies used by Nephraegis Therapeutics
Nephraegis Therapeutics News & Media
Nephraegis Therapeutics Launches with Seed Financing to Develop Small Molecules to Prevent and Treat Acute Kidney Injury (AKI)
LAKE FOREST, Ill.--(BUSINESS WIRE)-- #acutekidneyinjury--Nephraegis Therapeutics announces their launch with a seed investment from Xontogeny to advance their lead compound through critical preclinical work
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Nephraegis Therapeutics
Nephraegis Therapeutics is a biopharmaceutical company targeting acute kidney injury (AKI) through its development of a family of proprietary drug candidates that have great promise to prevent and treat AKI. Their lead compound NPH-022 is an epoxyeicosatrienoic-related compound (EET) with optimized pharmacokinetic properties.... Read More